Bulletin
Investor Alert

London Markets Open in:

Market Pulse Archives

Jan. 25, 2021, 12:38 p.m. EST

J&J may share findings from Phase 3 vaccine trial this week

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Johnson & Johnson (JNJ)
  • X
    BioNTech SE ADR (BNTX)
  • X
    Pfizer Inc. (PFE)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.19% were up 0.9% in trading on Monday, as the company nears the anticipated disclosure of interim results from a late-stage clinical trial evaluating its single-dose COVID-19 vaccine candidate. J&J said in mid-December it expects to share findings from the Phase 3 trial by the end of January, which would it the third company testing coronavirus vaccines in the U.S. to announce results from a closely watched Phase 3 trial. The other two vaccines, developed by BioNTech SE /zigman2/quotes/214419716/composite BNTX -4.75% /Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.53% and Moderna Inc. /zigman2/quotes/205619834/composite MRNA -6.73% , are both mRNA-based vaccines that received emergency use authorization from the Food and Drug Administration in December. J&J said in December that it will file for emergency authorization for its experimental adenovirus-based vaccine in February if results are ready by the end of January. The company is expected to release its fourth-quarter and full-year earnings on Tuesday. J&J's stock has gained 10.9% over the past year, while the S&P 500 /zigman2/quotes/210599714/realtime SPX -0.81% is up 15.6%.

/zigman2/quotes/201724570/composite
US : U.S.: NYSE
$ 159.02
-0.30 -0.19%
Volume: 7.61M
March 2, 2021 4:00p
P/E Ratio
28.85
Dividend Yield
2.54%
Market Cap
$418.80 billion
Rev. per Employee
$613,918
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 104.98
-5.23 -4.75%
Volume: 1.09M
March 2, 2021 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$26.54 billion
Rev. per Employee
$92,777
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 33.51
-0.18 -0.53%
Volume: 27.67M
March 2, 2021 4:02p
P/E Ratio
19.60
Dividend Yield
4.66%
Market Cap
$187.91 billion
Rev. per Employee
$533,860
loading...
/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 146.81
-10.59 -6.73%
Volume: 8.63M
March 2, 2021 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$62.92 billion
Rev. per Employee
$617,996
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
3,870.29
-31.53 -0.81%
Volume: 2.28B
March 2, 2021 5:08p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.